Stock Forecast Chart
Stock Price Prediction Summary
Forecast Score Based on 2 Weeks
Based on our forecast, the price of RIGL will decline by -2.32% over the next 2 Weeks and hit $47.06 by Friday, October 9, 2026. In that time frame, RIGL's share price is expected to range between $45.74 and $48.32.
BearishAverageBullish| Date | Predicted Lower | Predicted | Predicted Upper |
|---|---|---|---|
| Oct 9, 2026 | 46.12 | 47.51 | 48.96 |
| Oct 8, 2026 | 46.02 | 47.36 | 48.77 |
| Oct 7, 2026 | 46.47 | 47.92 | 49.17 |
| Oct 6, 2026 | 45.83 | 47.14 | 48.56 |
| Oct 5, 2026 | 45.54 | 46.83 | 48.00 |
| Oct 2, 2026 | 46.57 | 47.84 | 49.17 |
| Oct 1, 2026 | 46.41 | 47.69 | 48.95 |
| Sep 30, 2026 | 47.01 | 48.26 | 49.59 |
| Sep 29, 2026 | 46.20 | 47.48 | 48.68 |
| Sep 28, 2026 | 45.92 | 47.17 | 48.48 |
RIGL shares rose +0.61% in Friday, September 25, 2026's trading session, rising from a previous close of $47.89 to move at $48.18. The stock demonstrated notable intraday movement (see RIGL's key stats for a full breakdown), fluctuating between $47.20 and $48.54, a +2.83% trading range. While recent weeks have seen some volatility, RIGL has managed to secure a +1.99% gain over the past 2 weeks. The upward price movement was accompanied by increased trading volume, with approximately 204.93K shares changing hands, 61.12K more than the previous session. This amounted to $9.87M in total market activity.
Will RIGL Continue Its Upward Trend?
According to analyst ratings and projections for RIGL, Rigel Pharmaceuticals, Inc. shares are anticipated to increase by +1.59%, potentially reaching $48.96 per share by October 9, 2026. Short-term technical indicators currently suggest a neutral sentiment for RIGL. For deeper insights, view our sentiment analysis on AAPL covering social and institutional perspectives. However, the stock has recorded 16 positive trading days within the past 30 sessions. Based on the RIGL stock forecast, now is a good time to buy RIGL stock because its current trading price is +1.42% above our predicted value, hinting at a possible undervaluation. For deeper insights, view our sentiment analysis on RIGL covering social and institutional perspectives.
RIGL Technical Momentum: Overbought, Oversold, or Neutral?
An analysis of Relative Strength Index (RSI) indicators provides insight into RIGL's momentum. Short-term RSIs (9, 14, and 20-day figures ranging from 60.02% to 60.67%) suggest the stock is in a bullish momentum phase. The 50-day RSI, at 59.09%, suggests a neutral medium-term outlook. Additionally, the 100-day RSI, at 56.51%, maintains a neutral outlook for the long term. Insights into RIGL's shareholder base show how institutional investors are positioning themselves during these momentum shifts
Rigel Pharmaceuticals Short-Term Forecasts
RIGL Forecast For Next 5 Days
Our algorithm anticipates Rigel Pharmaceuticals (RIGL) stock could hit $49.05 by Oct 02, 2026. This represents a +1.80% fall from today's price, following a -9.06% change over the past five days.
RIGL Forecast For Next 30 Days
Based on analysis of market trends, the outlook for Rigel Pharmaceuticals, Inc. (RIGL) stock over the next 30 days is largely positive. Price forecasts suggest an average target of $49.59, which would mean a +2.93% increase from the current price of $48.18. Projections for this period range from a high of $56.58 to a low of $42.83.
RIGL Forecast For Next 90 Days
Our proprietary market analysis suggests predictions for Rigel Pharmaceuticals's price over the next three months point to a rise. RIGL stock is expected to peak at $58.77 on Nov 11, 2026 after potentially dipping to $43.55 on Oct 08, 2026. On average, RIGL is likely to trade around $49.72 in the coming 90 days.
Rigel Pharmaceuticals Stock Forecast 2025
Based on our predictive models, Rigel Pharmaceuticals (RIGL) is expected to trade between $43.55 and $58.77 throughout 2026. This would result in an average price of $49.70, potentially offering investors a +3.15% return from current levels.
Rigel Pharmaceuticals, Inc. Monthly Forecast 2026–2027
September 2026
According to our latest forecast models, Rigel Pharmaceuticals, Inc. (RIGL) is positioned to show a strong performance in September 2026. The price is predicted to move between $45.07 and $49.86, settling at an average of $47.54. This could translate to a -1.33% loss.
October 2026
Based on current market signals, Rigel Pharmaceuticals, Inc. is projected to trend october 2026. We forecast a trading range from $43.55 to $51.66, with a likely average price of $47.63. Investors could expect a potential return of -1.14%.
November 2026
Our predictive algorithms indicate Rigel Pharmaceuticals, Inc. stock may see a shift in November 2026. The expected range spans $47.57–$58.77, with an average target of $50.85. This represents a positive outlook and a possible gain of +5.54%.
December 2026
Analyzing established trends, Rigel Pharmaceuticals, Inc. looks set to move in December 2026. Projections place the stock between $47.16 and $54.48, averaging around $50.91. This suggests a +5.67% gain from current levels.
January 2027
Market indicators suggest Rigel Pharmaceuticals, Inc. could experience notable changes during January 2027. Prices could fluctuate within $46.07 to $53.34, with a midpoint forecast of $49.70. The stock might deliver a +3.15% gain.
February 2027
Forecasting for February 2027, models estimate that Rigel Pharmaceuticals, Inc. may undergo key fluctuations. If trends hold, the stock might trade between $48.61 and $55.47, averaging $52.36. This signals a positive trajectory with potential returns around +8.68%.
March 2027
According to our latest forecast models, Rigel Pharmaceuticals, Inc. (RIGL) is positioned to show a strong performance in March 2027. The price is predicted to move between $48.17 and $56.59, settling at an average of $52.20. This could translate to a +8.34% gain.
April 2027
Based on current market signals, Rigel Pharmaceuticals, Inc. is projected to trend april 2027. We forecast a trading range from $52.33 to $58.01, with a likely average price of $55.15. Investors could expect a potential return of +14.47%.
May 2027
Our predictive algorithms indicate Rigel Pharmaceuticals, Inc. stock may see a shift in May 2027. The expected range spans $51.41–$59.00, with an average target of $55.35. This represents a positive outlook and a possible gain of +14.88%.
June 2027
Analyzing established trends, Rigel Pharmaceuticals, Inc. looks set to move in June 2027. Projections place the stock between $50.66 and $57.81, averaging around $54.22. This suggests a +12.54% gain from current levels.
July 2027
Market indicators suggest Rigel Pharmaceuticals, Inc. could experience notable changes during July 2027. Prices could fluctuate within $53.31 to $60.12, with a midpoint forecast of $56.74. The stock might deliver a +17.77% gain.
August 2027
Forecasting for August 2027, models estimate that Rigel Pharmaceuticals, Inc. may undergo key fluctuations. If trends hold, the stock might trade between $52.54 and $61.91, averaging $56.98. This signals a positive trajectory with potential returns around +18.26%.
September 2027
According to our latest forecast models, Rigel Pharmaceuticals, Inc. (RIGL) is positioned to show a strong performance in September 2027. The price is predicted to move between $56.87 and $62.37, settling at an average of $59.58. This could translate to a +23.66% gain.
RIGL's history of dividends and stock splits also plays a role in long-term investor confidence.

